Activation of the Nrf-mediated anti-ROS cytoprotective pathway, Wnt/β-catenin signaling, and p53 contributed to the taxifolin-derived anticancer activities in colon cancer, breast cancer (BC), Ewing’s sarcoma, and cervical cancer [24,27,28]. Here, TP53 is linked to breast cancer.